Thanh Loc Nguyen

Dr. Thanh Loc Nguyen

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
TNThanh Loc Nguyen
Thanh Loc Nguyen
YCYoungjin Choi
Youngjin Choi
JIJihye Im
Jihye Im
HSHyunsu Shin
Hyunsu Shin
NPNgoc Man Phan
Ngoc Man Phan
Jaeyun KimJaeyun Kim
Jaeyun Kim
Current therapies for autoimmune diseases, such as multiple sclerosis (MS), induce broad suppression of the immune system, potentially promoting opportunistic infections. Here, we report an immunosuppressive biomaterial-based therapeutic vaccine carrying self-antigen and tolerance-inducing inorganic nanoparticles to treat experimental autoimmune encephalomyelitis (EAE), a mouse model mimicking human MS. Immunization with self-antigen-loaded mesoporous nanoparticles generates Foxp3+regulatory T-cells in spleen and systemic immune tolerance in EAE mice, reducing central nervous system-infiltrating antigen-presenting cells (APCs) and autoreactive CD4+T-cells. Introducing reactive oxygen species (ROS)-scavenging cerium oxide nanoparticles (CeNP) to self-antigen-loaded nanovaccine additionally suppresses activation of APCs and enhances antigen-specific immune tolerance, inducing recovery in mice from complete paralysis at the late, chronic stage of EAE, which shows similarity to chronic human MS. This study clearly shows that the ROS-scavenging capability of catalytic inorganic nanoparticles could be utilized to enhance tolerogenic features in APCs, leading to antigen-specific immune tolerance, which could be exploited in treating MS.

26 March 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
VPV.H. Giang Phan
V.H. Giang Phan
MMMohanapriya Murugesan
Mohanapriya Murugesan
MPManivasagan Panchanathan
Manivasagan Panchanathan
TNThanh Loc Nguyen
Thanh Loc Nguyen
PHPhan Thuy Hien
Phan Thuy Hien
Thambi ThavasyappanThambi Thavasyappan
Thambi Thavasyappan
Despite the potential of hydrogel-based localized cancer therapies, their efficacy can be limited by cancer recurrence. Therefore, it is of great significance to develop a hydrogel system that can provoke robust and durable immune response in the human body. This study has developed an injectable protein-polymer-based porous hydrogel network composed of lysozyme and poly(ε-caprolactone-co-lactide)-b-poly(ethylene glycol)-b-poly(ε-caprolactone-co-lactide (PCLA) (Lys-PCLA) bioconjugate for the active recruitment dendritic cells (DCs). The Lys-PCLA bioconjugates are prepared using thiol-ene reaction between thiolated lysozyme (Lys-SH) and acrylated PCLA (PCLA-Ac). The free-flowing Lys-PCLA bioconjugate sols at low temperature transformed to immovable gel at the physiological condition and exhibited stability upon dilution with buffers. According to the in vitro toxicity test, the Lys-PCLA bioconjugate and PCLA copolymer were non-toxic to RAW 263.7 cells at higher concentrations (1000 µg/mL). In addition, subcutaneous administration of Lys-PCLA bioconjugate sols formed stable hydrogel depot instantly, which suggested the in situ gel forming ability of the bioconjugate. Moreover, the Lys-PCLA bioconjugate hydrogel depot formed at the interface between subcutaneous tissue and dermis layers allowed the active migration and recruitment of DCs. As suggested by these results, the in-situ forming injectable Lys-PCLA bioconjugate hydrogel depot may serve as an implantable immune niche for the recruitment and modification of DCs.

15 October 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
XMXin Wang Mo
Xin Wang Mo
NPNgoc Man Phan
Ngoc Man Phan
TNThanh Loc Nguyen
Thanh Loc Nguyen
Jaeyun KimJaeyun Kim
Jaeyun Kim

23 August 2024 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
NPNgoc Man Phan
Ngoc Man Phan
TNThanh Loc Nguyen
Thanh Loc Nguyen
YCYoungjin Choi
Youngjin Choi
XMXin Wang Mo
Xin Wang Mo
TTThuy An Trinh
Thuy An Trinh
Jaeyun KimJaeyun Kim
Jaeyun Kim

11 December 2025 in Biomacromolecules
Verified
Journal Article
Closed access
TTThuy An Trinh
Thuy An Trinh
NPNgoc Man Phan
Ngoc Man Phan
TNThanh Loc Nguyen
Thanh Loc Nguyen
Jaeyun KimJaeyun Kim
Jaeyun Kim